Valuation: Southern Acids (M)

Market Cap 41Cr 10Cr 8.93Cr 8.31Cr 7.63Cr 14Cr 973.73Cr 15Cr 99Cr 39Cr 480.81Cr 38Cr 37Cr 1.66TCr P/E 2024
32.3x
P/E 2025 11.4x
Enterprise Value 4.8Cr 1.18Cr 1.03Cr 96.19L 88.34L 1.66Cr 112.72Cr 1.68Cr 11Cr 4.47Cr 56Cr 4.41Cr 4.32Cr 192.38Cr EV / Sales 2024
0.07x
EV / Sales 2025 0.05x
Free-Float
26.64%
Yield 2024
1.55%
Yield 2025 1.64%
1 day-1.30%
1 week-0.98%
Current month-3.50%
3 months-0.66%
6 months-4.72%
Current year-4.72%
1 week 3.02
Extreme 3.02
3.1
1 month 3.02
Extreme 3.02
3.12
Current year 2.99
Extreme 2.99
3.5
1 year 2.99
Extreme 2.99
3.6
3 years 2.82
Extreme 2.82
3.85
5 years 2.82
Extreme 2.82
4.3
10 years 2.7
Extreme 2.7
5.25
Manager TitleAgeSince
Chief Executive Officer 47 15/07/2015
Director of Finance/CFO 58 01/10/2013
Chief Tech/Sci/R&D Officer 38 16/07/2014
Director TitleAgeSince
Director/Board Member 66 10/08/2005
Director/Board Member 59 20/03/2012
Chairman 79 15/07/2015
Change 5-day change 1-year change 3-year change Capi.($)
-1.30%-0.98%-12.43%-15.83% 10Cr
+2.86%-1.04%+27.73%+421.84% 561.13Cr
+0.14%-2.12%+25.89%+103.02% 171.54Cr
+6.63%+9.80%+17.69%+67.93% 80Cr
+0.92%-0.90%+38.74%+102.77% 55Cr
+4.09%-0.41%+17.33%+2.22% 54Cr
+3.98%-4.98%-23.69%-29.65% 47Cr
+0.20%+1.45%+6.47%+5.95% 37Cr
+2.87%+2.67%+29.58%-9.58% 36Cr
-0.18%-4.20%+18.67%+51.12% 29Cr
Average +2.02%+0.50%+14.60%+69.98% 108Cr
Weighted average by Cap. +2.50%+0.11%+23.21%+245.73%

Financials

2024 2025
Net sales 92Cr 23Cr 20Cr 18Cr 17Cr 32Cr 2.16TCr 32Cr 219.05Cr 86Cr 1.07TCr 85Cr 83Cr 3.69TCr 110.6Cr 27Cr 24Cr 22Cr 20Cr 38Cr 2.6TCr 39Cr 263.27Cr 102.82Cr 1.28TCr 101.6Cr 99Cr 4.43TCr
Net income 1.36Cr 33.37L 29.33L 27.3L 25.07L 47.08L 32Cr 47.71L 3.25Cr 1.27Cr 16Cr 1.25Cr 1.23Cr 55Cr 3.67Cr 89.82L 78.96L 73.5L 67.5L 1.27Cr 86Cr 1.28Cr 8.74Cr 3.41Cr 43Cr 3.37Cr 3.3Cr 147Cr
Net Debt -37Cr -9.11Cr -8.01Cr -7.45Cr -6.85Cr -13Cr -873.51Cr -13Cr -89Cr -35Cr -431.32Cr -34Cr -33Cr -1.49TCr -37Cr -8.98Cr -7.89Cr -7.35Cr -6.75Cr -13Cr -861.01Cr -13Cr -87Cr -34Cr -425.15Cr -34Cr -33Cr -1.47TCr
Logo Southern Acids (M)
Southern Acids (M) Berhad is a Malaysia-based company, which is engaged in manufacturing of oleochemical products and investments in other palm oil related sectors. The Company’s segments include Oleochemical Manufacturing, Healthcare Services, Milling & Cultivation, and Investments & Services. The Oleochemical Manufacturing Segment is involved in the manufacturing and marketing of fatty acids and glycerin with a production mix ratio of approximately 90:10 between fatty acids and glycerin. The Healthcare Services operates Sri Kota Specialist Medical Center (Sri Kota), a private tertiary hospital located in Klang, Selangor. The Milling & Cultivation segment is principally engaged in the processing of fresh fruit bunches (FFB) into crude palm oil (CPO) and palm kernels, as well as oil palm cultivation. Milling & Cultivation operates approximately two palm oil mills (POM) located in Riau, Indonesia with a combined milling capacity of approximately 100 metric tons (MT) per hour.
Employees
1,683
Date Price Change Volume
28/26/28 MYR 3.030 -1.30% 6,100
27/26/27 MYR 3.070 -0.97% 13,100
23/26/23 MYR 3.100 +1.31% 5,000
22/26/22 MYR 3.060 -1.29% 2,000
  1. Stock Market
  2. Stocks
  3. 5134 Stock